Yun Ding

Yun (Hannah) Ding is the Director of Bioassay at Eli Lilly and Company, where they currently serve as a Senior Scientific Lead Bioassay since 2023. Previously, they held the positions of Research Scientist and Postdoctoral Scientist at Eli Lilly, contributing significantly to various research initiatives from 2017 to 2022. With extensive experience in neuroscience, they earned a Doctor of Philosophy (Ph.D.) with a minor in Business from the University of Wisconsin-Madison, where they published notable research in the field. Earlier in their career, Yun worked as a Research Specialist at Meharry Medical College and Virginia Commonwealth University, focusing on neurodegenerative diseases and drug screening.